MDT P/E Ratio Analysis
Updated 105h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 20.9x compares a company's stock price to its earnings per share, meaning investors pay $20.90 for every $1 of annual earnings.
Sector Performance
45th percentileMDT
20.9x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
23.3x(Jun 2026)
Deep Analysis
The P/E ratio of 20.9x compares a company's stock price to its earnings per share, meaning investors pay $20.90 for every $1 of annual earnings.
This sits below the sector median of 23.4x, placing MDT at the 44th percentile among sector peers, so it is slightly cheaper than a typical peer. The trend data is not available: the year-over-year change is N/A and the quarter-over-quarter change is N/A, so there is no direction to infer from recent movements. With a below-median valuation but no trend to confirm whether that discount is widening or narrowing, the risk profile is neutral — the stock is neither expensive nor clearly undervalued on this metric alone. This supports the overall NEUTRAL verdict, as the P/E does not point strongly toward an opportunity or a red flag.
Frequently Asked Questions
What does the P/E Ratio tell investors about MDT?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are MDT's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master MDT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MDT research report →MDT
20.9x
Sector Median
23.1x
Sector Avg
33.7x
How MDT's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.